587 related articles for article (PubMed ID: 25168939)
1. Pharmacology and laboratory testing of the oral Xa inhibitors.
Samama MM; Meddahi S; Samama CM
Clin Lab Med; 2014 Sep; 34(3):503-17. PubMed ID: 25168939
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacologic and clinical characteristics of direct inhibitors of factor Xa: rivaroxaban, apixaban, edoxaban and betrixaban].
Meddahi S; Samama MM
J Mal Vasc; 2014 May; 39(3):183-94. PubMed ID: 24650612
[TBL] [Abstract][Full Text] [Related]
3. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
Sardar P; Chatterjee S; Lavie CJ; Giri JS; Ghosh J; Mukherjee D; Lip GY
Int J Cardiol; 2015 Jan; 179():279-87. PubMed ID: 25464465
[TBL] [Abstract][Full Text] [Related]
4. Advances in oral anticoagulation therapy - What's in the pipeline?
Rao PSS; Burkart T
Blood Rev; 2017 Jul; 31(4):205-211. PubMed ID: 28185693
[TBL] [Abstract][Full Text] [Related]
5. Novel oral anticoagulants--key messages for the angiologist.
Haas S; Spannagl M; Schellong SM
Vasa; 2012 May; 41(3):177-91. PubMed ID: 22565619
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring options and reversal agents for oral anticoagulants].
Thorup SB; Husted SE; Vang ML
Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
[TBL] [Abstract][Full Text] [Related]
7. Bleeding and antidotes in new oral anticoagulants.
Majeed A; Schulman S
Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
[TBL] [Abstract][Full Text] [Related]
8. [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes].
Dalén M; Hjemdahl P; Holmström M; Ivert T
Lakartidningen; 2014 Jun 11-17; 111(24):1064-8. PubMed ID: 25129916
[No Abstract] [Full Text] [Related]
9. Perioperative management of patients on new oral anticoagulants.
Lai A; Davidson N; Galloway SW; Thachil J
Br J Surg; 2014 Jun; 101(7):742-9. PubMed ID: 24777590
[TBL] [Abstract][Full Text] [Related]
10. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists.
Levy JH
Clin Lab Med; 2014 Sep; 34(3):443-52. PubMed ID: 25168936
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pharmacological aspects of new oral anticoagulants].
Haschke M
Ther Umsch; 2012 Nov; 69(11):657-60. PubMed ID: 23117669
[TBL] [Abstract][Full Text] [Related]
13. The new oral anticoagulants: a challenge for hospital formularies.
Merli GJ
Hosp Pract (1995); 2012 Aug; 40(3):126-8. PubMed ID: 23086101
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum.
Siddiqui F; Hoppensteadt D; Jeske W; Iqbal O; Tafur A; Fareed J
Clin Appl Thromb Hemost; 2019; 25():1076029619847524. PubMed ID: 31088146
[TBL] [Abstract][Full Text] [Related]
15. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
[No Abstract] [Full Text] [Related]
16. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
Fenger-Eriksen C; Münster AM; Grove EL
Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
[TBL] [Abstract][Full Text] [Related]
18. The novel anticoagulants: the surgeons' prospective.
Shamoun FE; Martin EN; Money SR
Surgery; 2013 Mar; 153(3):303-7. PubMed ID: 23218887
[TBL] [Abstract][Full Text] [Related]
19. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM;
Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209
[TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants--pharmacology, drug interactions, and side effects.
Dempfle CE
Semin Hematol; 2014 Apr; 51(2):89-97. PubMed ID: 24861792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
